Farther Finance Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Sell
4,610
-50
-1% -$21.1K 0.01% 802
2026
Q1
$2.21M Buy
4,660
+391
+9% +$197K 0.02% 608
2025
Q4
$1.99M Buy
4,269
+2,073
+94% +$962K 0.02% 581
2025
Q3
$936K Buy
2,196
+797
+57% +$309K 0.01% 758
2025
Q2
$536K Buy
1,399
+258
+23% +$93K 0.01% 876
2025
Q1
$395K Buy
1,141
+242
+27% +$77.8K 0.01% 895
2024
Q4
$270K Sell
899
-258
-22% -$90.2K 0.01% 851
2024
Q3
$470K Buy
1,157
+255
+28% +$93.4K 0.02% 611
2024
Q2
$284K Buy
902
+284
+46% +$92.3K 0.01% 690
2024
Q1
$204K Buy
618
+47
+8% +$14.4K 0.01% 677
2023
Q4
$155K Buy
571
+207
+57% +$51.2K 0.01% 642
2023
Q3
$89.6K Buy
364
+50
+16% +$13.7K 0.01% 599
2023
Q2
$95.3K Buy
314
+8
+3% +$2.22K 0.02% 477
2023
Q1
$80.7K Buy
306
+10
+3% +$2.54K 0.02% 469
2022
Q4
$71K Buy
+296
New +$66.3K 0.03% 407

Other funds holding HCA

Farther Finance Advisors's HCA Position: Q2 2026 in Review

Farther Finance Advisors reduced its HCA Healthcare (HCA) stake by 1.1% in Q2 2026, selling an estimated $21.1K and leaving 4,610 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #802.

Farther Finance Advisors first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.21M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Farther Finance Advisors held 4,610 shares of HCA Healthcare worth $1.8M as of Q2 2026.
  • Farther Finance Advisors sold 50 HCA Healthcare shares in Q2 2026, an estimated $21.1K.
  • HCA Healthcare made up 0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #802 holding.
  • Farther Finance Advisors first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's HCA Healthcare position peaked at $2.21M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.